Okunogbe A, Nugent R, Spencer G, et al. Economic impacts of overweight and obesity: current and future estimates for 161 countries. BMJ Glob Health. 2022;7(9):e009773.

Article  PubMed  PubMed Central  Google Scholar 

Cotter TG, Charlton M. Nonalcoholic steatohepatitis after liver transplantation. Liver Transpl. 2020;26(1):141–59.

Article  PubMed  Google Scholar 

Watt KD, Heimbach JK, Rizk M, et al. Efficacy and safety of endoscopic balloon placement for weight loss in patients with cirrhosis awaiting liver transplantation. Liver Transpl. 2021;27(9):1239–47.

Article  PubMed  Google Scholar 

Nair S, Cohen DB, Cohen MP, et al. Postoperative morbidity, mortality, costs, and long-term survival in severely obese patients undergoing orthotopic liver transplantation. Am J Gastroenterol. 2001;96(3):842–5.

Article  PubMed  Google Scholar 

Hakeem AR, Cockbain AJ, Raza SS, et al. Increased morbidity in overweight and obese liver transplant recipients: a single-center experience of 1325 patients from the United Kingdom. Liver Transpl. 2013;19(5):551–62.

Article  PubMed  Google Scholar 

Germani G, Laryea M, Rubbia-Brandt L, et al. Management of recurrent and de novo NAFLD/NASH after liver transplantation. Transplantation. 2019;103(1):57–67.

Article  PubMed  Google Scholar 

Younossi ZM, Stepanova M, Ong J, et al. Nonalcoholic steatohepatitis is the most rapidly increasing indication for liver transplantation in the United States. Clin Gastroenterol Hepatol. 2021;19(3):580-589.e5.

Article  PubMed  Google Scholar 

Rinella ME, Lazarus JV, Ratziu V, et al. A multisociety Delphi consensus statement on new fatty liver disease nomenclature. J Hepatol. 2023;79(6):1542–56.

Article  PubMed  Google Scholar 

Barone M, Viggiani MT, Losurdo G, et al. Systematic review with meta-analysis: post-operative complications and mortality risk in liver transplant candidates with obesity. Aliment Pharmacol Ther. 2017;46(3):236–45.

Article  PubMed  Google Scholar 

Purnell JQ. Definitions, classification, and epidemiology of obesity. In: Feingold KR, Anawalt B, Blackman MR, Boyce A, Chrousos G, Corpas E, de Herder WW, Dhatariya K, Dungan K, Hofland J, Kalra S, Kaltsas G, Kapoor N, Koch C, Kopp P, Korbonits M, Kovacs CS, Kuohung W, Laferrère B, Levy M, McGee EA, McLachlan R, New M, Purnell J, Sahay R, Shah AS, Singer F, Sperling MA, Stratakis CA, Trence DL, Wilson DP (eds). Endotext [Internet]. South Dartmouth (MA): MDText.com, Inc. 2023.

Sussman JB, Wiitala WL, Zawistowski M, et al. The Veterans Affairs Cardiac Risk Score: recalibrating the atherosclerotic cardiovascular disease score for applied use. Med Care. 2017;55(9):864–70.

Article  PubMed  PubMed Central  Google Scholar 

de Vries Y, von Meijenfeldt FA, Porte RJ. Post-transplant cholangiopathy: classification, pathogenesis, and preventive strategies. Biochim Biophys Acta Mol Basis Dis. 2018;1864(4 Pt B):1507–15.

Article  PubMed  Google Scholar 

Olthoff KM, Kulik L, Samstein B, et al. Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors. Liver Transpl. 2010;16:943e9.

Article  Google Scholar 

Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.

Article  PubMed  PubMed Central  Google Scholar 

Harrington CR, Levy P, Cabrera E, et al. Evolution of pretransplant cardiac risk factor burden and major adverse cardiovascular events in liver transplant recipients over time. Liver Transpl. 2023;29(6):581–90.

Article  PubMed  PubMed Central  Google Scholar 

Du AL, Danforth DJ, Waterman RS, et al. Is obesity associated with better liver transplant outcomes? A retrospective study of hospital length of stay and mortality following liver transplantation. Anesth Analg. 2022;135(1):118–27.

PubMed  Google Scholar 

VanWagner LB, Lapin B, Levitsky J, et al. High early cardiovascular mortality after liver transplantation. Liver Transpl. 2014;20(11):1306–16.

Article  PubMed  PubMed Central  Google Scholar 

Sastre L, García R, Gándara JG, et al. Incidence, predictors, and impact on survival of long-term cardiovascular events after liver transplantation. Transplantation. 2020;104(2):317–25.

Article  PubMed  Google Scholar 

Sastre L, García R, Viñals C, et al. Results of a multidisciplinary strategy to improve the management of cardiovascular risk factors after liver transplantation. Liver Transpl. 2022;28(8):1332–44.

Article  PubMed  Google Scholar 

Younossi ZM, Tampi RP, Racila A, et al. Economic and clinical burden of nonalcoholic steatohepatitis in patients with type 2 diabetes in the U.S. Diabetes Care. 2020;43(2):283–9.

Article  PubMed  Google Scholar 

Estes C, Razavi H, Loomba R, et al. Modeling the epidemic of nonalcoholic fatty liver disease demonstrates an exponential increase in burden of disease. Hepatology. 2018;67(1):123–33.

Article  PubMed  Google Scholar 

Estes C, Anstee QM, Arias-Loste MT, et al. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016–2030. J Hepatol. 2018;69(4):896–904.

Article  PubMed  Google Scholar 

Younossi ZM, Marchesini G, Pinto-Cortez H, et al. Epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: implications for liver transplantation. Transplantation. 2019;103(1):22–7.

Article  PubMed  Google Scholar 

Frigg A, Peterli R, Peters T, et al. Reduction in co-morbidities 4 years after laparoscopic adjustable gastric banding. Obes Surg. 2004;14(2):216–23.

Article  PubMed  Google Scholar 

Wilding JPH, Batterham RL, Calanna S, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989–1002.

Article  PubMed  Google Scholar 

Frías JP, Davies MJ, Rosenstock J, et al. Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes. N Engl J Med. 2021;385(6):503–15.

Article  PubMed  Google Scholar 

Singh P, Taufeeq M, Pesavento TE, et al. Comparison of the glucagon-like-peptide-1 receptor agonists dulaglutide and liraglutide for the management of diabetes in solid organ transplant: a retrospective study. Diabetes Obes Metab. 2020;22(5):879–84.

Article  PubMed  PubMed Central  Google Scholar 

Thangavelu T, Lyden E, Shivaswamy V. A retrospective study of glucagon-like peptide 1 receptor agonists for the management of diabetes after transplantation. Diabetes Ther. 2020;11(4):987–94.

Article  PubMed  PubMed Central  Google Scholar 

Mingrone G, Panunzi S, De Gaetano A, et al. Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial. Lancet. 2021;397(10271):293–304.

Article  PubMed  Google Scholar 

Lee Y, Tian C, Lovrics O, et al. Bariatric surgery before, during, and after liver transplantation: a systematic review and meta-analysis. Surg Obes Relat Dis. 2020;16(9):1336–47.

Article  PubMed  Google Scholar 

de Barros F, Cardoso Faleiro Uba PH. Liver transplantation and bariatric surgery:a new surgical reality: a systematic review of the best time for bariatric surgery. Updates Surg. 2021;73(5):1615–1622.

Lopez-Lopez V, Ruiz-Manzanera JJ, Eshmuminov D, et al. Are we ready for bariatric surgery in a liver transplant program? A meta-analysis Obes Surg. 2021;31(3):1214–22.

Article  PubMed  Google Scholar